About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: March 20, 2006
Tragedy in Britain – Magnifying the Risk in the Risk/Benefit Equation
By now you have probably heard the terrible story out out of the United Kingdom regarding six human volunteers in a Phase I study who became seriously ill almost immediately after taking a study medication. An analysis of the situation … Continue reading
Posted in Safety and Clinical Trials
Comments Off on Tragedy in Britain – Magnifying the Risk in the Risk/Benefit Equation